QT Imaging receives Israeli regulatory approval for scanner
What it means
- What to watch: Healthcare upside usually comes in discrete events — readouts, approvals and launches — rather than gradual trends.
- How the stock is trading: $QTI -4.46% in the latest session.
- Timing: It landed before the opening bell — early risers had it with their coffee, and the next session was the first that could react.
Where the stock stands
$QTI last traded at $2.25, -4.46% on the session. That puts it 93% shy of its 52-week high of $31.75 and 0.0% clear of its low of $2.25 — within a tenth of its 52-week low. Over the year it has ranged 1311% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $QTI page.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$QTI earnings in 16 days. These were on the calendar before this story and are not caused by it.
What to watch next
The $QTI page has the full chart, the filings and the valuation model behind every figure here. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $QTI sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. It reads bullish at medium severity because of “approval” in the wording, with nothing on the bearish side to offset it. It was matched to $QTI. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on July 28, 2026. $QTI has moved -15.09% ($2.65 to $2.25). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.